Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Harmony Biosciences Holdings (HRMY) Depreciation & Amortization (IS) (2024 - 2025)

Harmony Biosciences Holdings' Depreciation & Amortization (IS) history spans 2 years, with the latest figure at $7.4 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 24.53% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $25.3 million, up 5.07%, while the annual FY2025 figure was $25.3 million, 5.07% up from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $7.4 million at Harmony Biosciences Holdings, up from $6.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $7.4 million in Q4 2025 and bottomed at $6.0 million in Q2 2025.